325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO
Our colleague Mohana Ravindranath joins us to talk about Micky Tripathi, charged with coordinating how AI is used across different government agencies and more broadly across the health care industry....
3 Okt 202432min
From Tradeoffs: Race to the Bottom
We’re excited to share the first episode in a new podcast series on generic drugs from Tradeoffs. It’s called ‘Race to the Bottom,’ and each week the show examines the problems undermining the generic...
28 Sep 202428min
324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
Our colleague Jonathan Wosen joins us to discuss the recent setbacks and wins in oncology R&D, including Genentech's decision to shut down its cancer immunology group, and the global ambitions of Akes...
26 Sep 202432min
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the...
19 Sep 202435min
322: A new threat to Merck's blockbuster cancer treatment, Moderna's cutbacks, and obesity drugs for kids
STAT reporter Matt Herper joins us to break down all the angles of this week's tumultuous week in cancer immunotherapy, including his up-close look at Summit co-CEO Bob Duggan. We also discuss the lat...
12 Sep 202432min
321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target
We discuss the next big trend in obesity drug development — treatments that target the amylin hormone. Companies argue that these types of drugs could lead to less nausea and muscle loss, and the firs...
5 Sep 202435min
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the l...
29 Aug 202437min
From "Say More": What Happens When AI Decides Your Medical Coverage
This week, STAT's Casey Ross and Bob Herman joined the Boston Globe's "Say More" podcast to talk about their reporting on AI and Healthcare. We're sharing that episode here with you now. Enjoy!
23 Aug 202422min
